The measure of success at FDA is not the number of facilities inspected or new drugs approved, or the speed of approval processes, says commissioner Margaret Hamburg.
Journal:
Pharmaceutical Executive, Jul 1, 2009
Copyright:
© 2010 Advanstar Communications, Inc. All rights reserved.
http://digg.com/u1SNlV
No comments:
Post a Comment